|
|
Article: In- Depth Research on Schering-Plough Corp.
- Article from:
- M2 Presswire
- Article date:
- April 19, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-19 April 2007-Biotech News: In- Depth Research on Schering-Plough Corp(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:19042007
In- Depth Research on Schering-Plough Corp (NYSE:SGP)
Schering-Plough Corporation engages in the discovery, development, manufacture, and marketing of medical therapies and treatments worldwide. Its Prescription Pharmaceuticals segment offers NASONEX for nasal allergy symptoms and nasal polyps; CLARINEX for allergic rhinitis; FORADIL AEROLIZER for asthma and chronic obstructive pulmonary disease; ASMANEX TWISTHALER for asthma; PROVENTIL for the relief of bronchospasm; AVELOX for respiratory and skin infections; ...